Argentina vs Singapore: Treatment success rate for patients treated for MDR-TB
Argentina
45.0%
in 2022
Singapore
39.0%
in 2022
Argentina rank
147th
Singapore rank
150th
Treatment success rate for patients treated for MDR-TB over time
- Argentina
- Singapore
How they compare
Argentina currently reports 45.0% against 39.0% in Singapore, a difference of 6.0%.
That makes Argentina's figure about 1.2 times Singapore's.
The two have swapped places 3 times across 12 shared years of data; in 2011 it was Singapore ahead.
Argentina ranks 147th and Singapore ranks 150th of 163 countries.
Across the 2 decades both report, Argentina averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Argentina | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.3% | 47.7% | 19.3% | Singapore |
| 2020s | 40.3% | 36.7% | 3.7% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Argentina or Singapore?
- Argentina, at 45.0% against 39.0% in Singapore as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Argentina and Singapore?
- 6.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Singapore?
- 12 years are reported by both, from 2011 to 2022.
- How do Argentina and Singapore rank globally for treatment success rate for patients treated for mdr-tb?
- Argentina ranks 147th and Singapore ranks 150th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.